Metabolic dysfunction-associated fatty liver disease and mortality among Chinese adults: a prospective cohort study.
Xiaomo WangShouling WuXiaojie YuanShuohua ChenQingjiang FuYuanyuan SunYanqi LanShiqi HuYanhong WangYing LuShunxi QuLi WangPublished in: The Journal of clinical endocrinology and metabolism (2021)
MAFLD was associated with increased all-cause mortality among the Chinese population, which was different by the status of overweight/obesity, diabetes, other metabolic indicators, and second causes. MAFLD patients should be managed by metabolic indicators and second causes to fulfill precise treatment and management.
Keyphrases
- type diabetes
- end stage renal disease
- weight loss
- newly diagnosed
- metabolic syndrome
- chronic kidney disease
- weight gain
- insulin resistance
- cardiovascular disease
- physical activity
- peritoneal dialysis
- oxidative stress
- prognostic factors
- cardiovascular events
- glycemic control
- patient reported outcomes
- combination therapy
- smoking cessation